Sang Woo Lee1, Da Jung Jung1, Gi Seok Jeong2,3. 1. Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, 88 Olympic-Ro 43 Gil, Songpa-Gu, Seoul, 05505, Republic of Korea. 2. Biomedical Engineering Research Center, Asan Institute for Life Sciences, Asan Medical Center, 88 Olympic-Ro 43 Gil, Songpa-Gu, Seoul, 05505, Republic of Korea. gsjeong@amc.seoul.kr. 3. Department of Convergence Medicine, University of Ulsan College of Medicine, 88 Olympic-Ro 43 Gil, Songpa-Gu, Seoul, 05505, Republic of Korea. gsjeong@amc.seoul.kr.
Abstract
BACKGROUND: Three-dimensional (3D) cell cultures with architectural and biomechanical properties similar to those of natural tissue have been the focus for generating liver tissue. Microarchitectural organization is believed to be crucial to hepatic function, and 3D cell culture technologies have enabled the construction of tissue-like microenvironments, thereby leading to remarkable progress in vitro models of human tissue and organs. Recently, to recapitulate the 3D architecture of tissues, spheroids and organoids have become widely accepted as new practical tools for 3D organ modeling. Moreover, the combination of bioengineering approach offers the promise to more accurately model the tissue microenvironment of human organs. Indeed, the employment of sophisticated bioengineered liver models show long-term viability and functional enhancements in biochemical parameters and disease-orient outcome. RESULTS: Various 3D in vitro liver models have been proposed as a new generation of liver medicine. Likewise, new biomedical engineering approaches and platforms are available to more accurately replicate the in vivo 3D microarchitectures and functions of living organs. This review aims to highlight the recent 3D in vitro liver model systems, including micropatterning, spheroids, and organoids that are either scaffold-based or scaffold-free systems. Finally, we discuss a number of challenges that will need to be addressed moving forward in the field of liver tissue engineering for biomedical applications. CONCLUSION: The ongoing development of biomedical engineering holds great promise for generating a 3D biomimetic liver model that recapitulates the physiological and pathological properties of the liver and has biomedical applications.
BACKGROUND: Three-dimensional (3D) cell cultures with architectural and biomechanical properties similar to those of natural tissue have been the focus for generating liver tissue. Microarchitectural organization is believed to be crucial to hepatic function, and 3D cell culture technologies have enabled the construction of tissue-like microenvironments, thereby leading to remarkable progress in vitro models of human tissue and organs. Recently, to recapitulate the 3D architecture of tissues, spheroids and organoids have become widely accepted as new practical tools for 3D organ modeling. Moreover, the combination of bioengineering approach offers the promise to more accurately model the tissue microenvironment of human organs. Indeed, the employment of sophisticated bioengineered liver models show long-term viability and functional enhancements in biochemical parameters and disease-orient outcome. RESULTS: Various 3D in vitro liver models have been proposed as a new generation of liver medicine. Likewise, new biomedical engineering approaches and platforms are available to more accurately replicate the in vivo 3D microarchitectures and functions of living organs. This review aims to highlight the recent 3D in vitro liver model systems, including micropatterning, spheroids, and organoids that are either scaffold-based or scaffold-free systems. Finally, we discuss a number of challenges that will need to be addressed moving forward in the field of liver tissue engineering for biomedical applications. CONCLUSION: The ongoing development of biomedical engineering holds great promise for generating a 3D biomimetic liver model that recapitulates the physiological and pathological properties of the liver and has biomedical applications.
Entities:
Keywords:
3D in vitro liver model; Liver; Organoids; Spheroids
Authors: Sofia B Leite; Tiffany Roosens; Adil El Taghdouini; Inge Mannaerts; Ayla J Smout; Mustapha Najimi; Etienne Sokal; Fozia Noor; Christophe Chesne; Leo A van Grunsven Journal: Biomaterials Date: 2015-11-17 Impact factor: 12.479
Authors: Rui M Tostões; Sofia B Leite; Margarida Serra; Janne Jensen; Petter Björquist; Manuel J T Carrondo; Catarina Brito; Paula M Alves Journal: Hepatology Date: 2012-04 Impact factor: 17.425
Authors: Meritxell Huch; Craig Dorrell; Sylvia F Boj; Johan H van Es; Vivian S W Li; Marc van de Wetering; Toshiro Sato; Karien Hamer; Nobuo Sasaki; Milton J Finegold; Annelise Haft; Robert G Vries; Markus Grompe; Hans Clevers Journal: Nature Date: 2013-01-27 Impact factor: 49.962
Authors: Catherine A Lázaro; Emma J Croager; Claudia Mitchell; Jean S Campbell; Changpu Yu; Jessica Foraker; Jonathan A Rhim; George C T Yeoh; Nelson Fausto Journal: Hepatology Date: 2003-11 Impact factor: 17.425
Authors: Yuebang Yin; Marcel Bijvelds; Wen Dang; Lei Xu; Annemiek A van der Eijk; Karen Knipping; Nesrin Tuysuz; Johanna F Dekkers; Yijin Wang; Jeroen de Jonge; Dave Sprengers; Luc J W van der Laan; Jeffrey M Beekman; Derk Ten Berge; Herold J Metselaar; Hugo de Jonge; Marion P G Koopmans; Maikel P Peppelenbosch; Qiuwei Pan Journal: Antiviral Res Date: 2015-09-25 Impact factor: 5.970
Authors: Meritxell Huch; Helmuth Gehart; Ruben van Boxtel; Karien Hamer; Francis Blokzijl; Monique M A Verstegen; Ewa Ellis; Martien van Wenum; Sabine A Fuchs; Joep de Ligt; Marc van de Wetering; Nobuo Sasaki; Susanne J Boers; Hans Kemperman; Jeroen de Jonge; Jan N M Ijzermans; Edward E S Nieuwenhuis; Ruurdtje Hoekstra; Stephen Strom; Robert R G Vries; Luc J W van der Laan; Edwin Cuppen; Hans Clevers Journal: Cell Date: 2014-12-18 Impact factor: 41.582
Authors: Sathidpak Nantasanti; Bart Spee; Hedwig S Kruitwagen; Chen Chen; Niels Geijsen; Loes A Oosterhoff; Monique E van Wolferen; Nicolas Pelaez; Hille Fieten; Richard W Wubbolts; Guy C Grinwis; Jefferson Chan; Meritxell Huch; Robert R G Vries; Hans Clevers; Alain de Bruin; Jan Rothuizen; Louis C Penning; Baukje A Schotanus Journal: Stem Cell Reports Date: 2015-10-08 Impact factor: 7.765
Authors: Marta Kapałczyńska; Tomasz Kolenda; Weronika Przybyła; Maria Zajączkowska; Anna Teresiak; Violetta Filas; Matthew Ibbs; Renata Bliźniak; Łukasz Łuczewski; Katarzyna Lamperska Journal: Arch Med Sci Date: 2016-11-18 Impact factor: 3.318
Authors: Igor Gurevich; Sarah A Burton; Christie Munn; Makiko Ohshima; Madelyn E Goedland; Katherine Czysz; Deepika Rajesh Journal: Biol Open Date: 2020-12-16 Impact factor: 2.422
Authors: Hyun Kyoung Kang; Madina Sarsenova; Da-Hyun Kim; Min Soo Kim; Jin Young Lee; Eun-Ah Sung; Myung Geun Kook; Nam Gyo Kim; Soon Won Choi; Vyacheslav Ogay; Kyung-Sun Kang Journal: Cells Date: 2021-05-20 Impact factor: 6.600
Authors: Sarah E Blutt; Sue E Crawford; Carolyn Bomidi; Xi-Lei Zeng; James R Broughman; Matthew Robertson; Cristian Coarfa; Mary Elizabeth M Tessier; Tor Savidge; F Blaine Hollinger; Steven A Curley; Mark Donowitz; Mary K Estes Journal: Am J Physiol Gastrointest Liver Physiol Date: 2021-07-21 Impact factor: 4.871